APO Research
Talk to an analyst

APO RESEARCH · REPORT

General Anesthesia Drugs

General anesthetics are drugs that have the ability to bring about a reversible loss of consciousness. Anesthetists administer these drugs to induce or maintain general anaesthesia to facilitate surgery. Some of these drugs are also used in lower dosages for pain management.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

General anesthetics are drugs that have the ability to bring about a reversible loss of consciousness. Anesthetists administer these drugs to induce or maintain general anaesthesia to facilitate surgery. Some of these drugs are also used in lower dosages for pain management.

Selected research

Market Structure

Global General Anesthesia Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

2 January 2026195 pages

Choose your research edition.

Industry ResearchGeneral Anesthesia Drugs Industry Research Report 2026126 pages · $2,950 USDIndustry Growth & TrendsGlobal General Anesthesia Drugs Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal General Anesthesia Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal General Anesthesia Drugs Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal General Anesthesia Drugs Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

General anesthetics are drugs that have the ability to bring about a reversible loss of consciousness. Anesthetists administer these drugs to induce or maintain general anaesthesia to facilitate surgery. Some of these drugs are also used in lower dosages for pain management.

The major players in global General Anesthesia Drugs market include Astrazeneca, Fresenius-Kabi, B.Braun, etc. The top 3 players occupy about 40% shares of the global market. North America and Europe are main markets, they occupy about 60% of the global market. Propofol is the main type, with a share about 30%. Intravenous Anesthetics is the main application, which holds a share about 70%.

This report provides an overview of the global General Anesthesia Drugs market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

Read the full market overview

The study covers key producers of General Anesthesia Drugs and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents General Anesthesia Drugs sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the General Anesthesia Drugs market size, projected growth trends, production technologies, key applications, and end-use industries.

General Anesthesia Drugs Segment by Company

Astrazeneca

Fresenius-Kabi

AbbVie

Baxter Healthcare

B.Braun

Maruishi

Piramal

Hikma Pharmaceuticals

Mylan

Nhwa

Hengrui

Lunan

General Anesthesia Drugs Segment by Type

Propofol

Etomidate

Midazolam

Sevoflurane

Isoflurane

Others

General Anesthesia Drugs Segment by Application

Intravenous Anesthetics

Inhalational Anesthetics

General Anesthesia Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global General Anesthesia Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of General Anesthesia Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of General Anesthesia Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the General Anesthesia Drugs market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of General Anesthesia Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of General Anesthesia Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of General Anesthesia Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. General Anesthesia Drugs Industry Trends Table 2. General Anesthesia Drugs Industry Drivers Table 3. General Anesthesia Drugs Industry Opportunities and Challenges Table 4. General Anesthesia Drugs Industry Restraints Table 5. Global General Anesthesia Drugs Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global General Anesthesia Drugs Revenue Market Share by Manufacturers (2021-2026) Table 7. Global General Anesthesia Drugs Sales by Manufacturers (K L) & (2021-2026) Table 8. Global General Anesthesia Drugs Sales Market Share by Manufacturers Table 9. Global General Anesthesia Drugs Average Sales Price (US$/L) of Manufacturers (2021-2026) Table 10. Global General Anesthesia Drugs Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global General Anesthesia Drugs Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global General Anesthesia Drugs Manufacturers, Product Type & Application Table 13. Global General Anesthesia Drugs Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global General Anesthesia Drugs by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Propofol Table 17. Major Manufacturers of Etomidate Table 18. Major Manufacturers of Midazolam Table 19. Major Manufacturers of Sevoflurane Table 20. Major Manufacturers of Isoflurane Table 21. Major Manufacturers of Others Table 22. Global General Anesthesia Drugs Sales by Type 2021 VS 2025 VS 2032 (K L) Table 23. Global General Anesthesia Drugs Sales by Type (2021-2026) & (K L) Table 24. Global General Anesthesia Drugs Sales by Type (2027-2032) & (K L) Table 25. Global General Anesthesia Drugs Sales Market Share by Type (2021-2026) Table 26. Global General Anesthesia Drugs Sales Market Share by Type (2027-2032) Table 27. Global General Anesthesia Drugs Revenue by Type 2021 VS 2025 VS 2032 (K L) Table 28. Global General Anesthesia Drugs Revenue by Type (2021-2026) & (K L) Table 29. Global General Anesthesia Drugs Revenue by Type (2027-2032) & (K L) Table 30. Global General Anesthesia Drugs Revenue Market Share by Type (2021-2026) Table 31. Global General Anesthesia Drugs Revenue Market Share by Type (2027-2032) Table 32. Major Manufacturers of Intravenous Anesthetics Table 33. Major Manufacturers of Inhalational Anesthetics Table 34. Global General Anesthesia Drugs Sales by Application 2021 VS 2025 VS 2032 (K L) Table 35. Global General Anesthesia Drugs Sales by Application (2021-2026) & (K L) Table 36. Global General Anesthesia Drugs Sales by Application (2027-2032) & (K L) Table 37. Global General Anesthesia Drugs Sales Market Share by Application (2021-2026) Table 38. Global General Anesthesia Drugs Sales Market Share by Application (2027-2032) Table 39. Global General Anesthesia Drugs Revenue by Application 2021 VS 2025 VS 2032 (K L) Table 40. Global General Anesthesia Drugs Revenue by Application (2021-2026) & (K L) Table 41. Global General Anesthesia Drugs Revenue by Application (2027-2032) & (K L) Table 42. Global General Anesthesia Drugs Revenue Market Share by Application (2021-2026) Table 43. Global General Anesthesia Drugs Revenue Market Share by Application (2027-2032) Table 44. Global General Anesthesia Drugs Sales by Region: 2021 VS 2025 VS 2032 (K L) Table 45. Global General Anesthesia Drugs Sales by Region (2021-2026) & (K L) Table 46. Global General Anesthesia Drugs Sales Market Share by Region (2021-2026) Table 47. Global General Anesthesia Drugs Sales Forecasted by Region (2027-2032) & (K L) Table 48. Global General Anesthesia Drugs Sales Forecasted Market Share by Region (2027-2032) Table 49. North America General Anesthesia Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K L) Table 50. North America General Anesthesia Drugs Sales by Country (2021-2026) & (K L) Table 51. North America General Anesthesia Drugs Sales by Country (2027-2032) & (K L) Table 52. Europe General Anesthesia Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K L) Table 53. Europe General Anesthesia Drugs Sales by Country (2021-2026) & (K L) Table 54. Europe General Anesthesia Drugs Sales by Country (2027-2032) & (K L) Table 55. Asia Pacific General Anesthesia Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K L) Table 56. Asia Pacific General Anesthesia Drugs Sales by Country (2021-2026) & (K L) Table 57. Asia Pacific General Anesthesia Drugs Sales by Country (2027-2032) & (K L) Table 58. South America, Middle East and Africa General Anesthesia Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K L) Table 59. South America, Middle East and Africa General Anesthesia Drugs Sales by Country (2021-2026) & (K L) Table 60. South America, Middle East and Africa General Anesthesia Drugs Sales by Country (2027-2032) & (K L) Table 61. Global General Anesthesia Drugs Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 62. Global General Anesthesia Drugs Revenue by Region (2021-2026) & (US$ Million) Table 63. Global General Anesthesia Drugs Revenue by Region (2027-2032) & (US$ Million) Table 64. Global General Anesthesia Drugs Revenue Market Share by Region (2021-2026) Table 65. Global General Anesthesia Drugs Revenue Market Share by Region (2027-2032) Table 66. Astrazeneca Company Information Table 67. Astrazeneca Business Overview Table 68. Astrazeneca General Anesthesia Drugs Sales (K L), Price (US$/L), Revenue (US$ Million) and Gross Margin (2021-2026) Table 69. Astrazeneca General Anesthesia Drugs Product Portfolio Table 70. Astrazeneca Recent Development Table 71. Fresenius-Kabi Company Information Table 72. Fresenius-Kabi Business Overview Table 73. Fresenius-Kabi General Anesthesia Drugs Sales (K L), Price (US$/L), Revenue (US$ Million) and Gross Margin (2021-2026) Table 74. Fresenius-Kabi General Anesthesia Drugs Product Portfolio Table 75. Fresenius-Kabi Recent Development Table 76. AbbVie Company Information Table 77. AbbVie Business Overview Table 78. AbbVie General Anesthesia Drugs Sales (K L), Price (US$/L), Revenue (US$ Million) and Gross Margin (2021-2026) Table 79. AbbVie General Anesthesia Drugs Product Portfolio Table 80. AbbVie Recent Development Table 81. Baxter Healthcare Company Information Table 82. Baxter Healthcare Business Overview Table 83. Baxter Healthcare General Anesthesia Drugs Sales (K L), Price (US$/L), Revenue (US$ Million) and Gross Margin (2021-2026) Table 84. Baxter Healthcare General Anesthesia Drugs Product Portfolio Table 85. Baxter Healthcare Recent Development Table 86. B.Braun Company Information Table 87. B.Braun Business Overview Table 88. B.Braun General Anesthesia Drugs Sales (K L), Price (US$/L), Revenue (US$ Million) and Gross Margin (2021-2026) Table 89. B.Braun General Anesthesia Drugs Product Portfolio Table 90. B.Braun Recent Development Table 91. Maruishi Company Information Table 92. Maruishi Business Overview Table 93. Maruishi General Anesthesia Drugs Sales (K L), Price (US$/L), Revenue (US$ Million) and Gross Margin (2021-2026) Table 94. Maruishi General Anesthesia Drugs Product Portfolio Table 95. Maruishi Recent Development Table 96. Piramal Company Information Table 97. Piramal Business Overview Table 98. Piramal General Anesthesia Drugs Sales (K L), Price (US$/L), Revenue (US$ Million) and Gross Margin (2021-2026) Table 99. Piramal General Anesthesia Drugs Product Portfolio Table 100. Piramal Recent Development Table 101. Hikma Pharmaceuticals Company Information Table 102. Hikma Pharmaceuticals Business Overview Table 103. Hikma Pharmaceuticals General Anesthesia Drugs Sales (K L), Price (US$/L), Revenue (US$ Million) and Gross Margin (2021-2026) Table 104. Hikma Pharmaceuticals General Anesthesia Drugs Product Portfolio Table 105. Hikma Pharmaceuticals Recent Development Table 106. Mylan Company Information Table 107. Mylan Business Overview Table 108. Mylan General Anesthesia Drugs Sales (K L), Price (US$/L), Revenue (US$ Million) and Gross Margin (2021-2026) Table 109. Mylan General Anesthesia Drugs Product Portfolio Table 110. Mylan Recent Development Table 111. Nhwa Company Information Table 112. Nhwa Business Overview Table 113. Nhwa General Anesthesia Drugs Sales (K L), Price (US$/L), Revenue (US$ Million) and Gross Margin (2021-2026) Table 114. Nhwa General Anesthesia Drugs Product Portfolio Table 115. Nhwa Recent Development Table 116. Hengrui Company Information Table 117. Hengrui Business Overview Table 118. Hengrui General Anesthesia Drugs Sales (K L), Price (US$/L), Revenue (US$ Million) and Gross Margin (2021-2026) Table 119. Hengrui General Anesthesia Drugs Product Portfolio Table 120. Hengrui Recent Development Table 121. Lunan Company Information Table 122. Lunan Business Overview Table 123. Lunan General Anesthesia Drugs Sales (K L), Price (US$/L), Revenue (US$ Million) and Gross Margin (2021-2026) Table 124. Lunan General Anesthesia Drugs Product Portfolio Table 125. Lunan Recent Development Table 126. Key Raw Materials Table 127. Raw Materials Key Suppliers Table 128. General Anesthesia Drugs Distributors List Table 129. General Anesthesia Drugs Customers List Table 130. Research Programs/Design for This Report Table 131. Authors List of This Report Table 132. Secondary Sources Table 133. Primary Sources List of Figures Figure 1. General Anesthesia Drugs Product Image Figure 2. Global General Anesthesia Drugs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global General Anesthesia Drugs Market Size (2021-2032) & (US$ Million) Figure 4. Global General Anesthesia Drugs Sales (2021-2032) & (K L) Figure 5. Global General Anesthesia Drugs Average Price (US$/L) & (2021-2032) Figure 6. Global Top 5 and 10 General Anesthesia Drugs Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Propofol Image Figure 9. Etomidate Image Figure 10. Midazolam Image Figure 11. Sevoflurane Image Figure 12. Isoflurane Image Figure 13. Others Image Figure 14. Global General Anesthesia Drugs Sales by Type (2021 VS 2025 VS 2032) & (K L) Figure 15. Global General Anesthesia Drugs Sales Market Share 2021 VS 2025 VS 2032 Figure 16. Global General Anesthesia Drugs Sales Market Share by Type (2021-2032) Figure 17. Global General Anesthesia Drugs Revenue by Type (2021 VS 2025 VS 2032) & (K L) Figure 18. Global General Anesthesia Drugs Revenue Market Share 2021 VS 2025 VS 2032 Figure 19. Global General Anesthesia Drugs Revenue Market Share by Type (2021-2032) Figure 20. Intravenous Anesthetics Image Figure 21. Inhalational Anesthetics Image Figure 22. Global General Anesthesia Drugs Sales by Application (2021 VS 2025 VS 2032) & (K L) Figure 23. Global General Anesthesia Drugs Sales Market Share 2021 VS 2025 VS 2032 Figure 24. Global General Anesthesia Drugs Sales Market Share by Application (2021-2032) Figure 25. Global General Anesthesia Drugs Revenue by Application (2021 VS 2025 VS 2032) & (K L) Figure 26. Global General Anesthesia Drugs Revenue Market Share 2021 VS 2025 VS 2032 Figure 27. Global General Anesthesia Drugs Revenue Market Share by Application (2021-2032) Figure 28. North America General Anesthesia Drugs Sales and Growth Rate (2021-2032) & (K L) Figure 29. North America General Anesthesia Drugs Sales Market Share by Country (2021-2032) Figure 30. U.S. General Anesthesia Drugs Sales and Growth Rate (2021-2032) & (K L) Figure 31. Canada General Anesthesia Drugs Sales and Growth Rate (2021-2032) & (K L) Figure 32. Mexico General Anesthesia Drugs Sales and Growth Rate (2021-2032) & (K L) Figure 33. Europe General Anesthesia Drugs Sales and Growth Rate (2021-2032) & (K L) Figure 34. Europe General Anesthesia Drugs Sales Market Share by Country (2021-2032) Figure 35. Germany General Anesthesia Drugs Sales and Growth Rate (2021-2032) & (K L) Figure 36. France General Anesthesia Drugs Sales and Growth Rate (2021-2032) & (K L) Figure 37. U.K. General Anesthesia Drugs Sales and Growth Rate (2021-2032) & (K L) Figure 38. Italy General Anesthesia Drugs Sales and Growth Rate (2021-2032) & (K L) Figure 39. Netherlands General Anesthesia Drugs Sales and Growth Rate (2021-2032) & (K L) Figure 40. Asia Pacific General Anesthesia Drugs Sales and Growth Rate (2021-2032) & (K L) Figure 41. Asia Pacific General Anesthesia Drugs Sales Market Share by Country (2021-2032) Figure 42. China General Anesthesia Drugs Sales and Growth Rate (2021-2032) & (K L) Figure 43. Japan General Anesthesia Drugs Sales and Growth Rate (2021-2032) & (K L) Figure 44. South Korea General Anesthesia Drugs Sales and Growth Rate (2021-2032) & (K L) Figure 45. Southeast Asia General Anesthesia Drugs Sales and Growth Rate (2021-2032) & (K L) Figure 46. India General Anesthesia Drugs Sales and Growth Rate (2021-2032) & (K L) Figure 47. Australia General Anesthesia Drugs Sales and Growth Rate (2021-2032) & (K L) Figure 48. South America, Middle East and Africa General Anesthesia Drugs Sales and Growth Rate (2021-2032) & (K L) Figure 49. South America, Middle East and Africa General Anesthesia Drugs Sales Market Share by Country (2021-2032) Figure 50. Brazil General Anesthesia Drugs Sales and Growth Rate (2021-2032) & (K L) Figure 51. South Africa General Anesthesia Drugs Sales and Growth Rate (2021-2032) & (K L) Figure 52. Saudi Arabia General Anesthesia Drugs Sales and Growth Rate (2021-2032) & (K L) Figure 53. Turkey General Anesthesia Drugs Sales and Growth Rate (2021-2032) & (K L) Figure 54. Argentina General Anesthesia Drugs Sales and Growth Rate (2021-2032) & (K L) Figure 55. UAE General Anesthesia Drugs Sales and Growth Rate (2021-2032) & (K L) Figure 56. Egypt General Anesthesia Drugs Sales and Growth Rate (2021-2032) & (K L) Figure 57. Chile General Anesthesia Drugs Sales and Growth Rate (2021-2032) & (K L) Figure 58. Global General Anesthesia Drugs Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 59. Global General Anesthesia Drugs Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 60. North America General Anesthesia Drugs Revenue (2021-2032) & (US$ Million) Figure 61. North America General Anesthesia Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Europe General Anesthesia Drugs Revenue (2021-2032) & (US$ Million) Figure 63. Europe General Anesthesia Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Asia-Pacific General Anesthesia Drugs Revenue (2021-2032) & (US$ Million) Figure 65. Asia-Pacific General Anesthesia Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. South America, Middle East and Africa General Anesthesia Drugs Revenue (2021-2032) & (US$ Million) Figure 67. South America, Middle East and Africa General Anesthesia Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 68. General Anesthesia Drugs Value Chain Figure 69. Manufacturing Cost Structure Figure 70. General Anesthesia Drugs Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Propofol
  • Etomidate
  • Midazolam
  • Sevoflurane
  • Isoflurane
  • Others
Applications
  • Intravenous Anesthetics
  • Inhalational Anesthetics
Companies covered
  • Astrazeneca
  • Fresenius-Kabi
  • AbbVie
  • Baxter Healthcare
  • B.Braun
  • Maruishi
  • Piramal
  • Hikma Pharmaceuticals
  • Mylan
  • Nhwa
  • Hengrui
  • Lunan

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global General Anesthesia Drugs Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global General Anesthesia Drugs Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global General Anesthesia Drugs Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global General Anesthesia Drugs Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global General Anesthesia Drugs Market Dynamics
  1. 2.1 General Anesthesia Drugs Industry Trends
  2. 2.2 General Anesthesia Drugs Industry Drivers
  3. 2.3 General Anesthesia Drugs Industry Opportunities and Challenges
  4. 2.4 General Anesthesia Drugs Industry Restraints
3 General Anesthesia Drugs Market by Manufacturers
  1. 3.1 Global General Anesthesia Drugs Revenue by Manufacturers (2021-2026)
  2. 3.2 Global General Anesthesia Drugs Sales by Manufacturers (2021-2026)
  3. 3.3 Global General Anesthesia Drugs Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global General Anesthesia Drugs Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global General Anesthesia Drugs Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global General Anesthesia Drugs Manufacturers, Product Type & Application
  7. 3.7 Global General Anesthesia Drugs Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global General Anesthesia Drugs Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 General Anesthesia Drugs Players Market Share by Revenue in 2025
  11. 3.8.3 2025 General Anesthesia Drugs Tier 1, Tier 2, and Tier 3
4 General Anesthesia Drugs Market by Type
  1. 4.1 General Anesthesia Drugs Type Introduction
  2. 4.1.1 Propofol
  3. 4.1.2 Etomidate
  4. 4.1.3 Midazolam
  5. 4.1.4 Sevoflurane
  6. 4.1.5 Isoflurane
  7. 4.1.6 Others
  8. 4.2 Global General Anesthesia Drugs Sales by Type
  9. 4.2.1 Global General Anesthesia Drugs Sales by Type (2021 VS 2025 VS 2032)
  10. 4.2.2 Global General Anesthesia Drugs Sales by Type (2021-2032)
  11. 4.2.3 Global General Anesthesia Drugs Sales Market Share by Type (2021-2032)
  12. 4.3 Global General Anesthesia Drugs Revenue by Type
  13. 4.3.1 Global General Anesthesia Drugs Revenue by Type (2021 VS 2025 VS 2032)
  14. 4.3.2 Global General Anesthesia Drugs Revenue by Type (2021-2032)
  15. 4.3.3 Global General Anesthesia Drugs Revenue Market Share by Type (2021-2032)
5 General Anesthesia Drugs Market by Application
  1. 5.1 General Anesthesia Drugs Application Introduction
  2. 5.1.1 Intravenous Anesthetics
  3. 5.1.2 Inhalational Anesthetics
  4. 5.2 Global General Anesthesia Drugs Sales by Application
  5. 5.2.1 Global General Anesthesia Drugs Sales by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global General Anesthesia Drugs Sales by Application (2021-2032)
  7. 5.2.3 Global General Anesthesia Drugs Sales Market Share by Application (2021-2032)
  8. 5.3 Global General Anesthesia Drugs Revenue by Application
  9. 5.3.1 Global General Anesthesia Drugs Revenue by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global General Anesthesia Drugs Revenue by Application (2021-2032)
  11. 5.3.3 Global General Anesthesia Drugs Revenue Market Share by Application (2021-2032)
6 Global General Anesthesia Drugs Sales by Region
  1. 6.1 Global General Anesthesia Drugs Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global General Anesthesia Drugs Sales by Region (2021-2032)
  3. 6.2.1 Global General Anesthesia Drugs Sales by Region (2021-2026)
  4. 6.2.2 Global General Anesthesia Drugs Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America General Anesthesia Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America General Anesthesia Drugs Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe General Anesthesia Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe General Anesthesia Drugs Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific General Anesthesia Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific General Anesthesia Drugs Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa General Anesthesia Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa General Anesthesia Drugs Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global General Anesthesia Drugs Revenue by Region
  1. 7.1 Global General Anesthesia Drugs Revenue by Region
  2. 7.1.1 Global General Anesthesia Drugs Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global General Anesthesia Drugs Revenue by Region (2021-2026)
  4. 7.1.3 Global General Anesthesia Drugs Revenue by Region (2027-2032)
  5. 7.1.4 Global General Anesthesia Drugs Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America General Anesthesia Drugs Revenue (2021-2032)
  8. 7.2.2 North America General Anesthesia Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe General Anesthesia Drugs Revenue (2021-2032)
  11. 7.3.2 Europe General Anesthesia Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific General Anesthesia Drugs Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific General Anesthesia Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa General Anesthesia Drugs Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa General Anesthesia Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Astrazeneca
  2. 8.1.1 Astrazeneca Company Information
  3. 8.1.2 Astrazeneca Business Overview
  4. 8.1.3 Astrazeneca General Anesthesia Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Astrazeneca General Anesthesia Drugs Product Portfolio
  6. 8.1.5 Astrazeneca Recent Developments
  7. 8.2 Fresenius-Kabi
  8. 8.2.1 Fresenius-Kabi Company Information
  9. 8.2.2 Fresenius-Kabi Business Overview
  10. 8.2.3 Fresenius-Kabi General Anesthesia Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Fresenius-Kabi General Anesthesia Drugs Product Portfolio
  12. 8.2.5 Fresenius-Kabi Recent Developments
  13. 8.3 AbbVie
  14. 8.3.1 AbbVie Company Information
  15. 8.3.2 AbbVie Business Overview
  16. 8.3.3 AbbVie General Anesthesia Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 AbbVie General Anesthesia Drugs Product Portfolio
  18. 8.3.5 AbbVie Recent Developments
  19. 8.4 Baxter Healthcare
  20. 8.4.1 Baxter Healthcare Company Information
  21. 8.4.2 Baxter Healthcare Business Overview
  22. 8.4.3 Baxter Healthcare General Anesthesia Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Baxter Healthcare General Anesthesia Drugs Product Portfolio
  24. 8.4.5 Baxter Healthcare Recent Developments
  25. 8.5 B.Braun
  26. 8.5.1 B.Braun Company Information
  27. 8.5.2 B.Braun Business Overview
  28. 8.5.3 B.Braun General Anesthesia Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 B.Braun General Anesthesia Drugs Product Portfolio
  30. 8.5.5 B.Braun Recent Developments
  31. 8.6 Maruishi
  32. 8.6.1 Maruishi Company Information
  33. 8.6.2 Maruishi Business Overview
  34. 8.6.3 Maruishi General Anesthesia Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Maruishi General Anesthesia Drugs Product Portfolio
  36. 8.6.5 Maruishi Recent Developments
  37. 8.7 Piramal
  38. 8.7.1 Piramal Company Information
  39. 8.7.2 Piramal Business Overview
  40. 8.7.3 Piramal General Anesthesia Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Piramal General Anesthesia Drugs Product Portfolio
  42. 8.7.5 Piramal Recent Developments
  43. 8.8 Hikma Pharmaceuticals
  44. 8.8.1 Hikma Pharmaceuticals Company Information
  45. 8.8.2 Hikma Pharmaceuticals Business Overview
  46. 8.8.3 Hikma Pharmaceuticals General Anesthesia Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Hikma Pharmaceuticals General Anesthesia Drugs Product Portfolio
  48. 8.8.5 Hikma Pharmaceuticals Recent Developments
  49. 8.9 Mylan
  50. 8.9.1 Mylan Company Information
  51. 8.9.2 Mylan Business Overview
  52. 8.9.3 Mylan General Anesthesia Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Mylan General Anesthesia Drugs Product Portfolio
  54. 8.9.5 Mylan Recent Developments
  55. 8.10 Nhwa
  56. 8.10.1 Nhwa Company Information
  57. 8.10.2 Nhwa Business Overview
  58. 8.10.3 Nhwa General Anesthesia Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Nhwa General Anesthesia Drugs Product Portfolio
  60. 8.10.5 Nhwa Recent Developments
  61. 8.11 Hengrui
  62. 8.11.1 Hengrui Company Information
  63. 8.11.2 Hengrui Business Overview
  64. 8.11.3 Hengrui General Anesthesia Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Hengrui General Anesthesia Drugs Product Portfolio
  66. 8.11.5 Hengrui Recent Developments
  67. 8.12 Lunan
  68. 8.12.1 Lunan Company Information
  69. 8.12.2 Lunan Business Overview
  70. 8.12.3 Lunan General Anesthesia Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Lunan General Anesthesia Drugs Product Portfolio
  72. 8.12.5 Lunan Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 General Anesthesia Drugs Value Chain Analysis
  2. 9.1.1 General Anesthesia Drugs Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 General Anesthesia Drugs Production Mode & Process
  6. 9.2 General Anesthesia Drugs Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 General Anesthesia Drugs Distributors
  9. 9.2.3 General Anesthesia Drugs Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst